The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

A.V. Alekberzade

Kafedra khirurgii Pervogo moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova

N.N. Krylov

Klinika fakul'tetskoĭ khirurgii #1 lechebnogo fakul'teta Pervogo Moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova

Z. Adzhun

Upstate Medical University, Syracuse, NY, USA

M.R. Laftavi

Upstate Medical University, Syracuse, NY, USA

R.O. Shakhbazov

Upstate Medical University, Syracuse, NY, USA

K.S. Zuykova

Sechenov First Moscow State Medical University of Healthcare Ministry of the Russian Federation, Moscow, Russia

Current state of the problem of allotransplantation of Langerhans cells (achievements and prospects)

Authors:

A.V. Alekberzade, N.N. Krylov, Z. Adzhun, M.R. Laftavi, R.O. Shakhbazov, K.S. Zuykova

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2018;(11): 80‑88

Views: 2302

Downloaded: 78


To cite this article:

Alekberzade AV, Krylov NN, Adzhun Z, Laftavi MR, Shakhbazov RO, Zuykova KS. Current state of the problem of allotransplantation of Langerhans cells (achievements and prospects). Pirogov Russian Journal of Surgery. 2018;(11):80‑88. (In Russ.)
https://doi.org/10.17116/hirurgia201811180

Recommended articles:
New clinical deve­lopments in combination therapy for meta­static mela­noma: ASCO annual congress, June 2022. Russian Journal of Clinical Dermatology and Vene­reology. 2023;(3):329-336
Cell therapy in cardiology: a time for a hope. Russian Cardiology Bulletin. 2023;(4):7-18

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.